Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Hematopoietic cell transplantation for lymphomas Ayala E; Tomblyn MCancer Control 2011[Oct]; 18 (4): 246-57BACKGROUND: The heterogeneity of lymphomas results in numerous treatment options, including both autologous and allogeneic hematopoietic cell transplantation. However, the type of transplantation, the timing the procedure, and the selection of suitable patients for transplant continue to evolve. METHODS: We reviewed the current medical literature to provide a succinct synthesis for the most common types of lymphoma and the indications for transplantation. RESULTS: This review discusses the outcomes of autologous and allogeneic transplantation for patients with diffuse large B-cell lymphoma, follicular lymphoma, HIV-associated lymphomas, mantle cell lymphoma, T-cell lymphoma, and Hodgkin lymphoma. CONCLUSIONS: Each of these histologies differs in the indications and timing for transplantation. However, ongoing clinical trials support the continuing role of both autologous and allogeneic transplantation for lymphoma management.|Antineoplastic Combined Chemotherapy Protocols/therapeutic use[MESH]|Combined Modality Therapy[MESH]|Hematopoietic Stem Cell Transplantation/*methods[MESH]|Humans[MESH]|Lymphoma/classification/*therapy[MESH]|Survival Analysis[MESH]|Transplantation Conditioning/methods[MESH]|Transplantation, Autologous[MESH]|Transplantation, Homologous[MESH]|Treatment Outcome[MESH] |